SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
17317XOMA Licenses Antibody Technology to Pfizer Tuesday August 28, 8:05 am ET Initinigel bates-8/28/2007
17316financial guidance XOMA is providing the following guidance for 2007 which willbob zagorin-8/8/2007
1731510q xml.10kwizard.combob zagorin-8/8/2007
17314Upgrades Company Ticker Brokerage Firm Ratings Change Price Target XOMA Libob zagorin-8/1/2007
17313little xoma graps the #5 spot for the largest short increases in new data from nbob zagorin-7/25/2007
17312MEDX anti-IL1 is somewhat further ahead in the clinic - Message 23710724nigel bates-7/18/2007
17311there's a a great article in july Scientific American about this very topic.bob zagorin-7/16/2007
17310XOMA Initiates Phase I U.S. Trial in Type 2 Diabetes for XOMA 052, Monoclonal Annigel bates-7/16/2007
17309Cimzia looking interesting for RA, though - Message 23623707nigel bates-6/14/2007
17308whoops, susquehana just started xoma at positive so i'm back in for a littlebob zagorin-6/7/2007
17307fwiw, sold the rest of my xoma for a good gain (most bot below $2)... just lookibob zagorin-6/6/2007
17306I also wanted to touch on Xoma (XOMA), if possible. How does this company look tbob zagorin-5/21/2007
17305XOMA Reports First Quarter 2007 Results Thursday May 10, 4:00 pm ET BERKELEY, Cbob zagorin-5/10/2007
17304thanks. couple thoughts on isis... don't think its all in the price. there bob zagorin-4/27/2007
17303Scarred, bruised and battle fatigued..but still standing...well leaning a littleArthur Radley-4/26/2007
17302well tex, you're an old battle-scarred biotech vet like me... remember lgnd.bob zagorin-4/26/2007
17301Interesting news on Xoma being added to the list. More interesting is that I hadArthur Radley-4/26/2007
17300xoma will replace merck serono in healthshares ETF HealthShares(TM) Announces Cbob zagorin-4/26/2007
17299New 52 week high on large vol.with no news.Somethings brewing.nowandthen-4/23/2007
17298XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes Thursday Aprbob zagorin-4/12/2007
17297Roche Buys Biotech Firm THP Associated Press April 2, 2007 10:03 p.m. BASEL, Swbob zagorin-4/3/2007
17296this may be part of reason for xoma's short term slide... XOMA has licensingbob zagorin-3/29/2007
17295schwab upgrades xoma to market perform based on recent improvement in analyst sebob zagorin-3/26/2007
17294UCB Provides Update on <i>(potential delay for)</i> CIMZIA(TM) for Cnigel bates-3/23/2007
17293Xoma expands by 8,000 square feet Friday March 16, 12:44 pm ET Biopharmaceuticabob zagorin-3/16/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News